Protein Phosphatase 2A Orchestrates Mitochondrial Dynamics via MAPK Signaling in heart

This study demonstrates that cardiac-specific deletion of Protein Phosphatase 2A catalytic subunit (PP2Ac) disrupts mitochondrial dynamics by causing ERK2 hyperphosphorylation, which upregulates Fis1 and Drp1-mediated fission, leading to excessive mitophagy and hypertrophic cardiomyopathy.

The Gist

The Big Picture: The Heart's Power Plant Crisis

Imagine your heart is a high-performance race car engine. To keep running, it needs a massive amount of fuel (ATP). The "power plants" inside the engine cells are called mitochondria.

In a healthy heart, these power plants are dynamic. They are constantly merging together to share resources (fusion) and splitting apart to get rid of broken parts (fission). It's like a busy construction crew that knows exactly when to build a new wall and when to tear down a damaged one.

This study looks at what happens when a specific "foreman" inside the heart cell goes missing. That foreman is a protein called PP2A. When the researchers removed this foreman from the hearts of baby mice, the power plants went into chaos, the engine stalled, and the mice died very young.

The Story of the Missing Foreman (PP2A)

1. The Foreman's Job:
PP2A is a "de-phosphatase." Think of phosphorylation as a "switch" that turns proteins on or off. PP2A's job is to flip the "off" switch on certain proteins to keep them calm and balanced. Without PP2A, these switches get stuck in the "ON" position.

2. The Chain Reaction:
When the foreman (PP2A) is gone, a protein called ERK2 gets stuck in the "ON" position. It becomes hyper-active.

• The Analogy: Imagine ERK2 is a loud, hyperactive alarm system. Normally, PP2A keeps the alarm volume down. Without PP2A, the alarm screams at maximum volume.

3. The Alarm Moves to the Control Room:
Because this alarm (ERK2) is so loud, it doesn't just stay in the hallway; it runs straight into the "Control Room" (the cell nucleus). Once there, it starts shouting orders to the cell's DNA.

4. The Bad Order: "Break Everything Down!"
The loud alarm tells the cell to produce a protein called Fis1.

• The Analogy: Fis1 is like a demolition crew foreman. When the alarm tells the demolition crew to work overtime, they start tearing down the power plants (mitochondria) way too fast.

The Consequence: A City in Ruins

Because the demolition crew (Fis1) is working overtime, the mitochondria get chopped up into tiny, useless pieces.

• The Result: The heart cells can't make enough energy (ATP). The "race car" runs out of gas.
• The Cleanup: The cell tries to clean up the mess by eating the broken pieces (a process called mitophagy), but there is so much damage that the cleanup crew gets overwhelmed.
• The Outcome: The heart muscle becomes weak, swells up (hypertrophy), and eventually fails. The baby mice die around 12 days old because their hearts simply can't keep up with the demand.

How They Figured It Out

The researchers used a few clever tricks to solve this mystery:

1. The Microscope: They looked at the heart cells under a super-powerful electron microscope and saw the mitochondria were swollen, broken, and scattered, unlike the neat, rod-shaped ones in healthy hearts.
2. The "Photo" of Chemical Tags: They took a "snapshot" of all the chemical tags (phosphorylation) on the proteins. They found that without the PP2A foreman, the ERK2 alarm was covered in too many "ON" tags.
3. The Lab Test: They used drugs to mimic the missing foreman in a petri dish. When they blocked PP2A, the ERK2 alarm went off, the demolition crew (Fis1) showed up, and the mitochondria shattered. When they blocked the alarm (ERK2) or the demolition crew (Fis1), the chaos stopped.

The Takeaway: A New Way to Fix the Engine

This study is important because it connects three things that were previously thought to be separate:

1. PP2A (The Foreman)
2. ERK2 (The Alarm)
3. Mitochondrial Dynamics (The Power Plants)

The "So What?":
The researchers suggest that in people with heart failure, this same "alarm system" might be stuck in the "ON" position. If we can develop drugs to:

• Turn down the ERK2 alarm, OR
• Stop the demolition crew (Fis1) from tearing things apart,

We might be able to stop the heart from failing. It's like finding a way to silence the false alarm so the construction crew can get back to building a strong, healthy heart.

In short: A missing protein causes a false alarm, which orders the cell to destroy its own power plants, leading to heart failure. Fixing the alarm could save the heart.

Technical Summary

1. Problem Statement

The mammalian heart is a high-energy-demand organ reliant on mitochondrial oxidative phosphorylation. During postnatal development, the heart undergoes a critical metabolic transition from anaerobic to aerobic metabolism, accompanied by the maturation of mitochondrial architecture through coordinated fusion and fission (mitochondrial dynamics). Dysregulation of these dynamics is a hallmark of heart failure, yet the specific phosphorylation events governing mitochondrial quality control during this developmental window remain poorly understood. Specifically, the role of Protein Phosphatase 2A (PP2A), a major serine/threonine phosphatase, in regulating mitochondrial dynamics and preventing early-onset cardiomyopathy is not fully characterized.

2. Methodology

The study employed a multi-faceted approach combining in vivo genetic models, in vitro cell culture, and high-throughput omics:

• Animal Model: The researchers utilized a cardiac-specific knockout (KO) mouse model ($Ppp2ca^{fl/fl}$ crossed with $\alpha$-MHC-Cre) to conditionally delete the PP2A catalytic subunit $\alpha$ (PP2Ac$\alpha$) starting at postnatal day 6.5 (P6.5).
• Phenotypic Analysis:
  • Transmission Electron Microscopy (TEM): To assess mitochondrial ultrastructure, size, aspect ratio, and cristae integrity at P7, P9, and P11.
  • Functional Assays: Oxygen Consumption Rate (OCR) via Seahorse XF24 analyzer, ATP/ADP ratios via HPLC, and mitochondrial membrane potential ($\Delta\psi_m$) via flow cytometry (JC-1 dye).
• Phosphoproteomics: Heart tissues were subjected to iTRAQ-labeled LC-MS/MS analysis to identify global phosphorylation changes. Data were filtered for upregulated phosphosites (Log2FC $\ge$ 1) and analyzed via Gene Ontology (GO) and KEGG pathway enrichment.
• Molecular Validation:
  • Co-immunoprecipitation (Co-IP): To verify physical interactions between PP2Ac$\alpha$ and ERK2 under varying detergent stringencies.
  • Cell Culture Models: H9c2 cardiomyoblasts were treated with Okadaic Acid (OA, a PP2A inhibitor) or U0126 (a MEK1/2 inhibitor) and transfected with siRNA against PP2Ac$\alpha$ to mimic the KO phenotype.
  • Subcellular Localization: Confocal microscopy was used to track the nuclear translocation of phosphorylated ERK2 (p-ERK2).
  • Gene Expression: RT-qPCR and Western blotting were used to quantify expression levels of mitochondrial dynamics proteins (Fis1, Drp1, Mfn1/2, OPA1) and mitophagy markers (P62).
  • Mitophagy Assays: Cells were treated with CCCP to induce depolarization, followed by imaging of mitochondrial-lysosome colocalization.

3. Key Contributions

• Mechanistic Link: Established a direct causal link between PP2Ac$\alpha$ deficiency, hyperphosphorylation of ERK2, and pathological mitochondrial fission.
• Phosphoproteomic Discovery: Identified the MAPK signaling pathway as the predominant downstream effector of PP2Ac$\alpha$ loss in the developing heart, specifically pinpointing ERK2 (MAPK1) as the critical node.
• Spatiotemporal Dynamics: Demonstrated that PP2A directly dephosphorylates ERK2 at dual sites (T183/Y185), regulating its subcellular localization. Loss of PP2A causes rapid nuclear accumulation of p-ERK2.
• Transcriptional Regulation: Revealed that nuclear p-ERK2 drives the transcriptional upregulation of Fis1 (Mitochondrial fission 1), shifting the balance toward excessive fission.
• Pathological Consequence: Connected excessive fission to accelerated mitophagy and energy failure, identifying this cascade as the cause of early mortality in the KO mice.

4. Key Results

• Phenotype: PP2Ac$\alpha$ KO mice developed hypertrophic cardiomyopathy and died suddenly around P12.
• Mitochondrial Morphology: KO hearts exhibited a dramatic shift from rod-shaped to spherical mitochondria (increased aspect ratio initially, then fragmentation), swelling, and cristae collapse by P11.
• Metabolic Failure: KO mitochondria showed reduced ATP yield (86% of control), impaired ADP/ATP conversion, and dissipated membrane potential.
• Phosphoproteomics: Out of 90 proteins with altered phosphorylation, the MAPK pathway was the most significantly enriched. ERK2 showed hyperphosphorylation.
• PP2A-ERK2 Interaction: Co-IP confirmed a direct, tight interaction between PP2Ac$\alpha$ and ERK2. Inhibition of PP2A (via OA or siRNA) led to rapid, transient hyperphosphorylation of ERK2 at T183/Y185.
• Nuclear Translocation: Hyperphosphorylated ERK2 accumulated in the nucleus of KO cardiomyocytes (P7) and OA-treated cells. This nuclear accumulation was blocked by U0126 (MEK inhibitor).
• Fis1 Upregulation: Nuclear p-ERK2 increased Fis1 mRNA and protein levels. Consequently, Fis1 recruited Drp1 to the mitochondrial outer membrane, driving excessive fission.
• Mitophagy: The fragmented mitochondria were targeted for degradation. KO hearts and OA-treated cells showed increased P62/SQSTM1 accumulation and colocalization of mitochondria with lysosomes, indicating excessive mitophagy leading to energy depletion.
• Rescue Potential: Inhibiting MEK1/2 with U0126 prevented Fis1 transcription and mitochondrial fragmentation in H9c2 cells, suggesting the pathway is druggable.

5. Significance

• Novel Regulatory Axis: The study defines a novel PP2A-ERK2-Fis1 axis that controls mitochondrial quality control during the critical window of postnatal heart maturation.
• Therapeutic Insight: It suggests that the hyperphosphorylation of ERK2 is a critical driver of adverse remodeling in heart failure. Targeting this specific phosphorylation event or the downstream MAPK signaling could offer a therapeutic strategy to prevent hypertrophic cardiomyopathy and early mortality.
• Developmental Context: The findings highlight that mitochondrial dynamics are not static but are dynamically regulated by phosphorylation events essential for the metabolic transition from fetal to adult heart function.
• Limitations & Future Directions: The authors note the inability to perform a full in vivo rescue experiment due to technical constraints in neonatal mice. Future work aims to identify the specific transcription factor mediating p-ERK2's regulation of the Fis1 promoter.

In conclusion, this paper elucidates how the loss of PP2Ac$\alpha$ disrupts mitochondrial homeostasis via uncontrolled ERK2 phosphorylation, leading to excessive fission, mitophagy, and heart failure, thereby positioning MAPK signaling modulation as a potential target for cardioprotection.